Dexmethylphenidate Hydrochloride Extended-Release (dexmethylphenidate hydrochloride) — NDC 0527-8111 by Lannett Company, Inc.
Dexmethylphenidate Hydrochloride Extended-Release (dexmethylphenidate hydrochloride) — NDC 0527-8111 by Lannett Company, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Dexmethylphenidate Hydrochloride Extended-Release; Generic name: dexmethylphenidate hydrochloride; Product NDC:
| Brand name | Dexmethylphenidate Hydrochloride Extended-Release |
|---|---|
| Generic name | dexmethylphenidate hydrochloride |
| Product NDC | 0527-8111 |
| Labeler | Lannett Company, Inc. |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active ingredients | DEXMETHYLPHENIDATE HYDROCHLORIDE 30 mg/1 |
| Pharmacologic class | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE] |
| Marketing category | ANDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| DEA schedule | CII |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →